Back to Search
STEVEN TREON, MD, PHD
MD, PHD
Specialist
NPI: 1821060138Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Primary therapy of Waldenström macroglobulinemia with bortezomib, dexamethasone, and rituximab: WMCTG clinical trial 05-180.
PMID 19506160·J Clin Oncol·2009
3-trial
Advances in the biology and treatment of Waldenström's macroglobulinemia: a report from the 5th International Workshop on Waldenström's Macroglobulinemia, Stockholm, Sweden.
PMID 19362961·Clin Lymphoma Myeloma·2009
8-other
Lenalidomide and rituximab in Waldenstrom's macroglobulinemia.
PMID 19118065·Clin Cancer Res·2009
3-trial
Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia.
PMID 19015393·Blood·2009
3-trial
Waldenstrom's macrogloblinemia/ lymphoplasmacytic lymphoma.
PMID 18283788·Cancer Treat Res·2008
6-review
Novel agents in the treatment of Waldenström's macroglobulinemia.
PMID 17877845·Clin Lymphoma Myeloma·2007
6-review
Multicenter clinical trial of bortezomib in relapsed/refractory Waldenstrom's macroglobulinemia: results of WMCTG Trial 03-248.
PMID 17545538·Clin Cancer Res·2007
3-trial
Update on treatment recommendations from the Third International Workshop on Waldenstrom's macroglobulinemia.
PMID 16410453·Blood·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 44 BINNEY ST..
BOSTON, MA 02115 - Phone
- (617) 632-4166
Quick Facts
- NPI
- 1821060138
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile